I saw your advert in the paper <a href=" http://verulamwebdesign.co.uk/zyprexa-metabolism.pdf ">zyprexa 2.5mg</a> The rejected proposal was for four board representatives each from Vivus and FMC, and one independent investor representative, Vivus said. The four FMC nominees proposed would include three recommended by proxy advisory firm ISS plus a new CEO, Vivus said in a statement.